-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Author Archives: christalpowell
Coronavirus today and the SCI community tomorrow
I’m not going to sugar coat the Coronavirus situation. Even as I begin writing this post, the numbers continue to grow geometrically for new coronavirus cases around the world. The day started out with around 460 cases in the USA … Continue reading
Posted in Uncategorized
Comments Off on Coronavirus today and the SCI community tomorrow
Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
Four months after treating them, Yasuhiro Shiga, MD, PhD, checked on his rats. Walking into the lab, he carried minimal expectations. Treating spinal cord injuries with stem cells had been tried by many people, many times before, with modest success … Continue reading
Posted in Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Akina Shiga, Alysson R. Muotri, and Steven L. Gonias, Chanond Nasamran, Chiba University; Pinar Mesci, Coralie Brifault, HyoJun Kwon, Jacob J. Jeziorski, John H. Kim, Seiji Ohtori, Yasuhiro Shiga
Comments Off on Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
Authors *I. VENKATESH1, Z. WANG2, V. MEHRA1, E. EASTWOOD1, M. SIMPSON1, A. CHAKRABORTY1, D. GROSS1, Z.BEINE1, M. CABAHUG1, G. OLSON1, M. G. BLACKMORE3;2Dept. of Biomed. Sci., 3Biomed. Sci., 1Marquette Univ., Milwaukee, WI Lab Abstract Embryonic and peripheral neurons respond to … Continue reading
Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
Authors: *N. DE LA OLIVA1, A. E. HAGGERTY1, M. A. PEREZ1,2, M. OUDEGA1,2,3,4; 1 Miami Project To Cure Paralysis, Univ. of Miami, Miami, FL; 2 Bruce W. Carter Dept. of Veterans Affairs Med. Ctr., Miami, FL; 3 Affiliated Cancer Hosp. … Continue reading
Effect of PTEN antagonist peptide on the functional motor recovery in rat
Authors: *S. LV1, W. WU2; 1 Guangdong-hongkong-Macau Inst. of CNS Regeneration, Guangzhou, China; 2 The Univ.Of Hong Kong, Hong Kong SAR, Hong Kong Lab Abstract: Ventral root injury results in great loss of motor functions because of the inefficient axon … Continue reading
GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
Authors:*P. M. ABDUL-MUNEER, S. BHOWMICK, V. D’MELLO; Hackensack Meridian Hlth. JFK Med. Ctr., Edison, NJ Neuroscience 2019 LINK Lab Abstract: Spinal cord injury (SCI) occurs when there is damage from trauma, loss of normal blood supply, or a mass effect … Continue reading
GTX Medical and NeuroRecovery Technologies to merge
GTX Medical and NeuroRecovery Technologies today announced their merger into a global company for the development of neuromodulation therapies for spinal cord injuries. The two merging companies plan to develop the targeted epidural spine stimulation system, an implantable spinal cord … Continue reading
Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
QUEBEC CITY, CANADA, October 10th 2019 – Today, Laboratoires Guertin announces that a campaign for funding has been launched to support a phase IIb-enabling pilot study with a tritherapy candidate (buspirone/L-DOPA/carbidopa)called Spinalon. This experimental oral pill has been shown to … Continue reading
Moving beyond the glial scar for spinal cord repair
Authors: Elizabeth J. Bradbury and Emily R. Burnside Abstract: Traumatic spinal cord injury results in severe and irreversible loss of function. The injury triggers a complex cascade of inflammatory and pathological processes, culminating in formation of a scar. While traditionally … Continue reading
The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
Author: James W. Fawcett Abstract: Axon regeneration in the CNS is inhibited by many extrinsic and intrinsic factors. Because these act in parallel, no single intervention has been sufficient to enable full regeneration of damaged axons in the adult mammalian … Continue reading
Posted in Chronic Spinal Cord Injury Research, Gene Therapy, Ligand, spinal cord injury research, Stem Cell Research
Tagged Dr. James Fawcett
Comments Off on The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?